QA: Carisma Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2018_Carisma_Therapeutics_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001485003')"}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc.

  xvar xval
0 AssetsCurrent 14,981,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 522,000
3 remainder_Assets 130,000
4 LiabilitiesCurrent 4,720,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,070,000
9 ResearchAndDevelopmentExpense 12,510,000
10 remainder_Expenses 9,100,000
11 remainder_Revenues 0
12 remainder_NetIncome 651,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 75,097,000
1 Liabilities 4,720,000
2 Expenses 29,680,000
3 Revenues 0
4 StockholdersEquity 70,377,000
5 NetIncome -29,029,000
6 ComprehensiveNetIncome -29,029,000
7 BaseVar 55,074,000
8 EconomicCapitalRatio 2.31

Edgar->Model Mapping

Feature Distribution

Change over Time